Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018
High dose psilocybin is associated with positive subjective effects in healthy volunteers
Nicholas, C. R., Henriquez, K. M., Gassman, M. C., Cooper, K. M., Muller, D., Hetzel, S., ... & Hutson, P. R. | Journal of Psychopharmacology | 27 June 2018
Psychedelics and hypnosis: Commonalities and therapeutic implications
Lemercier, C. E., & Terhune, D. B. | Journal of Psychopharmacology | 25 June 2018
Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects
Vizeli, P., & Liechti, M. E. | PloS one | 18 June 2018
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., ... & Tófoli, L. F. | Psychological medicine | 15 June 2018
Dark Classics in Chemical Neuroscience: Mescaline
Cassels, B., & Sáez-Briones, P. | ACS chemical neuroscience | 8 June 2018
Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes
Mash, D. C., Duque, L., Page, B., & Allen-Ferdinand, K. | Frontiers in Pharmacology | 5 June 2018
A Survey of American Psychiatrists’ Attitudes Toward Classic Hallucinogens
Barnett, B. S., Siu, W. O., & Pope Jr, H. G. | The Journal of nervous and mental disease | 1 June 2018
Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
Gabay, A. S., Carhart-Harris, R. L., Mazibuko, N., Kempton, M. J., Morrison, P. D., Nutt, D. J., & Mehta, M. A. | Scientific reports | 29 May 2018
Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
Cata-Preta, E. G., Serra, Y. A., Moreira-Junior, E. D. C., Reis, H. S., Kisaki, N. D., Libarino-Santos, M., ... & Costa, J. L. | Frontiers in pharmacology | 29 May 2018
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Duman, R. S. | F1000Research | 24 May 2018
Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
Shadli, S. M., Kawe, T., Martin, D., McNaughton, N., Neehoff, S., & Glue, P. | International Journal of Neuropsychopharmacology | 24 April 2018
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
Rong, C., Park, C., Rosenblat, J. D., Subramaniapillai, M., Zuckerman, H., Fus, D., ... & Cha, D. S. | International journal of environmental research and public health | 17 April 2018
A role for enhanced functions of sleep in psychedelic therapy?
Froese, T., Leenen, I., & Palenicek, T. | Adaptive Behavior | 4 April 2018
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
Carrillo, F., Sigman, M., Slezak, D. F., Ashton, P., Fitzgerald, L., Stroud, J., ... & Carhart-Harris, R. L. | Journal of affective disorders | 30 March 2018
Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature
Grady, S. E., Marsh, T. A., Tenhouse, A., & Klein, K. | Mental Health Clinician | 23 March 2018
Four weekly ayahuasca sessions lead to increases in “acceptance” capacities: a comparison study with a standard 8-week mindfulness training program
Soler, J., Elices, M., Dominguez-Clave, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., ... & Riba, J. | Frontiers in Pharmacology | 20 March 2018
Role of the 5-HT2A receptor in self- and other-initiated social interaction in LSD-induced states – a pharmacological fMRI study
Preller, K. H., Schilbach, L., Pokorny, T., Flemming, J., Seifritz, E., & Vollenweider, F. X. | Journal of Neuroscience | 19 March 2018
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M. C., Lorusso, M., ... & Lerner, A. G. | Brain sciences | 16 March 2018
Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial
Gálvez, V., Li, A., Huggins, C., Glue, P., Martin, D., Somogyi, A. A., ... & Loo, C. K. | Journal of Psychopharmacology | 15 March 2018
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. | Handbook of Experimental Pharmacology | 13 March 2018
The entropic brain – Revisited
Carhart-Harris, R. L. | Neuropharmacology | 13 March 2018
Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats
Horsley, R. R., Páleníček, T., Kolin, J., & Valeš, K. | Behavioural pharmacology | 13 March 2018
Acute pharmacological effects of 2C-B in humans: An observational study
Papaseit, E., Farré, M., Perez-Maña, C., Torrens, M., Ventura, M., Pujadas, M., ... & González, D. | Frontiers in Pharmacology | 13 March 2018
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Feduccia, A. A., & Mithoefer, M. C. | Progress in neuro-psychopharmacology and biological psychiatry | 7 March 2018